InvestorsHub Logo

AVII77

05/26/17 8:24 AM

#106929 RE: ggwpq #106928

I agree. The LDL-c hypothesis is questionable.

But two wrongs don't make a right.

If we want to say that the FDA should have approved V based on ANCHOR's trig reduction, then we must be ready to agree they should have approved Evacetrapib based on its lipid effects too. (And of course, ACCELERATE shows that would have been a mistake)

rafunrafun

05/26/17 9:17 AM

#106933 RE: ggwpq #106928

Was Jupiter the only successful statin trial or were there others?

There is something about statins that doesn't sit right with me.